Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 21;346(6212):987-91.
doi: 10.1126/science.1259595. Epub 2014 Oct 30.

Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance

Affiliations

Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance

Angela L Rasmussen et al. Science. .

Abstract

Existing mouse models of lethal Ebola virus infection do not reproduce hallmark symptoms of Ebola hemorrhagic fever, neither delayed blood coagulation and disseminated intravascular coagulation nor death from shock, thus restricting pathogenesis studies to nonhuman primates. Here we show that mice from the Collaborative Cross panel of recombinant inbred mice exhibit distinct disease phenotypes after mouse-adapted Ebola virus infection. Phenotypes range from complete resistance to lethal disease to severe hemorrhagic fever characterized by prolonged coagulation times and 100% mortality. Inflammatory signaling was associated with vascular permeability and endothelial activation, and resistance to lethal infection arose by induction of lymphocyte differentiation and cellular adhesion, probably mediated by the susceptibility allele Tek. These data indicate that genetic background determines susceptibility to Ebola hemorrhagic fever.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Distinct Morbidity and Mortality Following MA-EBOV Infection in CC-RIX Mouse Lines
A. Percent of starting body weight over course of infection in susceptible (red squares) and resistant mice (blue circles). Data shown are mean ± SEM from five mice per CC-RIX line. B. Kaplan-Meier survival curve for susceptible (red) and resistant (blue) mice. Five mice were used for each CC-RIX line. C,D,E,F. Gross appearance of liver at necropsy in uninfected susceptible (C) and resistant (E) mice, and on day 5 post-infection in susceptible (D) and resistant (F) mice.
Figure 2
Figure 2. MA-EBOV Replication in CC-RIX Mouse Lines
A,B. Quantitative real-time PCR showing expression of MA-EBOV genomes relative to mouse 18S rRNA in spleen (A) and liver (B). Data shown are mean ± SEM for three mice per time point per RIX line. C,D. Titration of infectious MA-EBOV in organ homogenates from spleen (C) and liver (D) quantified as focus forming units per milliliter. No infectious virus was detected prior to day 3 p.i. Data shown are mean ± SEM from two experiments using 2–3 mice per time point per CC-RIX line. E,F,G,H. Immunohistochemical staining for VP40 in resistant liver (E,F) and susceptible liver (G,H). Arrow indicates representative hepatocyte morphology. (t-test, *p<0.05)
Figure 3
Figure 3. Quantification of Coagulopathy and Hemorrhage in CC-RIX Mouse Lines
A,B,C. Coagulation times in seconds for thrombin (A), prothrombin (B), and activated partial thromboplastin (C) over course of MA-EBOV infection. D. Serum fibrinogen levels in CC-RIX mice over course of MA-EBOV infection. All data shown are the mean ± SEM for 2 experiments including 2–5 animals per time point. (ANOVA with Tukey’s HSD post-hoc. *p<0.05, **p<0.05, ***p<0.0000001).
Figure 4
Figure 4. Distinct Host Responses Associated with Disease Phenotype
A,B. Number of differentially expressed genes (DEG) either up-regulated (positive y-axis) or down-regulated (negative y-axis) relative to time-matched mock-infected samples in spleen (A) and liver (B).

References

    1. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. Journal of comparative pathology. 2001 Nov;125:243. - PubMed
    1. Yen JY, et al. Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. The Journal of infectious diseases. 2011 Nov;204(Suppl 3):S1043. - PubMed
    1. Ebihara H, et al. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. The Journal of infectious diseases. 2011 Nov;204(Suppl 3):S991. - PMC - PubMed
    1. Geisbert TW, et al. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. The Journal of infectious diseases. 2003 Dec 1;188:1618. - PubMed
    1. Connolly BM, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. The Journal of infectious diseases. 1999 Feb;179(Suppl 1):S203. - PubMed

Publication types

MeSH terms

Associated data